Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Cash from Investing Activities (2017 - 2025)

Cue Biopharma (CUE) has disclosed Cash from Investing Activities for 9 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 702100.0% to $7.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $75000.0 through Dec 2025, up 134.38% year-over-year, with the annual reading at $75000.0 for FY2025, 134.38% up from the prior year.
  • Cash from Investing Activities hit $7.0 million in Q4 2025 for Cue Biopharma, up from -$6.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $15.0 million in Q1 2023 to a low of -$29.5 million in Q3 2022.
  • Historically, Cash from Investing Activities has averaged $505658.5 across 5 years, with a median of -$10000.0 in 2024.
  • Biggest YoY gain for Cash from Investing Activities was 978177.89% in 2022; the steepest drop was 268263.64% in 2022.
  • Year by year, Cash from Investing Activities stood at $511.0 in 2021, then skyrocketed by 978177.89% to $5.0 million in 2022, then grew by 0.02% to $5.0 million in 2023, then plummeted by 100.02% to -$1000.0 in 2024, then surged by 702100.0% to $7.0 million in 2025.
  • Business Quant data shows Cash from Investing Activities for CUE at $7.0 million in Q4 2025, -$6.8 million in Q3 2025, and -$27000.0 in Q2 2025.